Abstract
Responsibility for the protection of human research subjects is shared by investigators, research ethics committees, sponsors/funders, research institutions, governments and, the focus of this article, physicians who enrol patients in clinical trials. The article describes the general principles of the patient-physician relationship that should regulate the participation of physicians in clinical trials and proposes guidelines for determining when and how such participation should proceed. The guidelines deal with the following stages of the trial: when first considering participation, when deciding whether to enrol patients, when asking patients to participate, when the trial is underway and when it is completed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Annas, George J. and Grodin, Michael A. (1992) The Nazi Doctors and the Nuremberg Code: Human Rights in Human Experimentation. Oxford University Press, New York.
Beecher, Henry K. (1966) Ethical and Clinical Research. New England Journal of Medicine 274: 1354–1360.
Baldwin-Ragaven L, de Gruchy J, London L, editors (1999). An ambulance of the wrong colour. Health professionals, human rights and ethics in South Africa. Cape Town: University of Cape Town Press.
Steinbrook, R. (2002) Protecting Research Subjects — The Crisis at Johns Hopkins. New England Journal of Medicine 346: 716–720.
Koski, Greg (2004) Research Policy. I. General Background. In: Post, Steven G., editor. Encyclopedia of Bioethics, 3rd edition. New York: Macmillan Reference USA, 2357–2365.
Kopelman, Loretta M. (2004) Research Policy. II. Risk and Vulnerable Groups. In Post, Steven G., editor. Encyclopedia of Bioethics, 3rd edition. New York: Macmillan Reference USA, 2365–2372.
International Dual Loyalty Working Group (2002) Dual Loyalty & Human Rights in Health Professional Practice: Proposed Guidelines & Institutional Mechanisms (www.phrusa.org/healthrights/dual_loyalty.html)
Oath of Hippocrates. In: Post, Steven G., editor (2004) Encyclopedia of Bioethics, 3rd edition. New York: Macmillan Reference USA, 2650.
WMA: Declaration of Geneva, www.wma.net/e/policy/c8.htm
WMA: Declaration of Helsinki, www.wma.net/e/policy/b3.htm
WMA: Declaration on the Rights of the Patient, www.wma.net/e/policy/14.htm
WMA: Declaration of Helsinki, www.wma.net/e/policy/b3.htm
www.coe.int/T/E/Legal_affairs/legal_co-operation/Bioethics/Texts_and_documents/1Treaties_COE.asp#TopOfPage
www.cioms.ch/frame_guidelines_nov_2002.htm
Lowry, F (1994) Dr. Roger Poisson: “I Have Learned My Lesson the Hard Way.” Canadian Medical Association Journal 151: 835–837.
World Medical Association (2002). Statement Concerning the Relationship of Physicians and Commercial Enterprises, www.wma.net/e/policy/r2.htm
The Standing Committee of European Doctors and the European Federation of Pharmaceutical Industries and Associations (2005), Cooperation between the Medical Profession and the Pharmaceutical Industry, http://213.49.133.32:591/database/CPMEEFPIA%20Joint%20Declaration.pdf
Cf. the other contributions to this special issue of the Journal.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Williams, J.R. The physician’s role in the protection of human research subjects. SCI ENG ETHICS 12, 5–12 (2006). https://doi.org/10.1007/PL00022264
Issue Date:
DOI: https://doi.org/10.1007/PL00022264